Daily market insights on Telegram
Share Predictions

Stocks

Stock predictionsToday's rankings and AI sentiment SectorsWhere each part of the market leans Stock directoryEvery U.S. stock, A to Z AI trading portfolioA simulation of the predictions Penny stocks portfolioA simulation, for penny stocks

Options

Options chainCalls and puts for any U.S. stock Options predictionsEvery closed one, wins and losses Options directoryEvery optionable stock, A to Z Options guidesFrom Greeks to spreads, in plain words

Apps

SharePredsStocks OpPredsOptions CPredsCrypto TradeSimSimulator Average CostCalculator All apps

Tools

All trading tools Get SharePreds

BioXcel Therapeutics, Inc. Common Stock (BTAI) stock analysis and AI prediction

The company facts of BioXcel Therapeutics, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.

Keep looking in SharePreds

You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.

QR code that opens SharePreds in your phone's app storeScan with your phone
See all five apps
SharePreds ranking U.S. stocks by their chance of rising over the next 10 days

About BioXcel Therapeutics, Inc. Common Stock

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are-BXCL501, being evaluated as a potential treatment for agitation associated with multiple neurological disorders and BXCL701, an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer and other solid and liquid tumors. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Exchange
NASDAQ
Market value
$22.5 million
Employees
29
Headquarters
NEW HAVEN, CT
Listed since
March 8, 2018

BTAI questions

What is the AI prediction for BTAI stock?

Each market day our model rates BioXcel Therapeutics, Inc. Common Stock (BTAI) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.

How often is the BTAI prediction updated?

Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.

What do Bullish, Neutral and Bearish mean?

Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.

Where can I see the exact likelihood for BTAI?

In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.

Where can I see BTAI options?

The BTAI options page opens its calls and puts, with price, volume, implied volatility and the Greeks.